BREAST CANCER

This adverse event was reported 34981 times

These drugs are most commonly taken by patients reporting BREAST CANCER:

# Drug Count
0 CONJUGATED ESTROGENS 9578
1 ESTROGENS, CONJUGATED 9332
2 MEDROXYPROGESTERONE ACETATE 8187
3 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 7864
4 ESTRADIOL 1788
5 ETANERCEPT 1736
6 INTERFERON BETA-1A 1394
7 METHOTREXATE SODIUM 1352
8 METHOTREXATE 1235
9 INFLIXIMAB 1179
See all common drugs associated with BREAST CANCER

BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OLAPARIB 9 1.8000
1 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 7864 0.3472
2 NORETHINDRONE ACETATE/ETHINYL ESTRADIOL 307 0.2748
3 MEDROXYPROGESTERONE ACETATE 8187 0.2473
4 ESTRADIOL/NORETHINDRONE ACETATE 281 0.2250
5 ESTRADIOL AND NORETHINDRONE ACETATE 288 0.2159
6 CONJUGATED ESTROGENS 9578 0.1871
7 ESTROGENS, CONJUGATED 9332 0.1843
8 ESTROPIPATE 138 0.1535
9 ESTRADIOL, ESTRIOL, FOLLICULINUM 89 0.1188
See all drugs enriched for association with BREAST CANCER

BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 129 0.0028
1 Nonsteroidal Anti-inflammatory Drug [EPC] 38 0.0025
2 Insulin Analog [EPC] 536 0.0023
3 Prostaglandin Analog [EPC] 2 0.0023
4 GLP-2 Analog [EPC] 7 0.0019
5 Leptin Analog [EPC] 1 0.0017
6 Stimulant Laxative [EPC] 17 0.0017
7 Angiotensin Converting Enzyme Inhibitor [EPC] 119 0.0014
8 Antiarrhythmic [EPC] 7 0.0009
9 Tetracycline-class Drug [EPC] 26 0.0008
See all drug classes enriched for association with BREAST CANCER